je.st
news
Tag: biotech
Cambridge rare disease biotech Synageva to be acquired for $8.4B
2015-05-06 13:59:14| Biotech - Topix.net
Cambridge rare disease biotech Synageva BioPharma Corp. will be acquired for $8.4 billion by Connecticut-based Alexion Pharmaceuticals, the two companies announced today.
Tags: disease
rare
acquired
cambridge
The Wall Street Journal: Alexion to buy Synageva in $8.4 billion biotech deal
2015-05-06 13:59:13| Biotech - Topix.net
Alexion Pharmaceuticals Inc. has agreed to buy Synageva BioPharma Corp. in a cash-and-stock deal valued at $8.4 billion, a move that will strengthen Alexion's pipeline of rare-disease treatments. shareholder will receive $115 in cash and 0.6581 Alexion share, for a total consideration of about $225.92 a share based on Alexion's After the deal, Alexion will have eight treatments in clinical trials, including Synageva's experimental enzyme-replacement therapy for patients with mucopolysaccharidosis IIIB, a rare metabolic disease.
Glasgow could fill 'Valley of Death' in biotech with...
2015-05-05 23:20:23| Biotech - Topix.net
The All-Energy 2015 Conference is being held on May 6 and 7 at the SECC in Glasgow and will hear about opportunities for the city and Scotland. MORE than 7000 delegates are meeting in Glasgow this week to look at how Scotland could lead the way on biotechnology.
Biotech Leader provides testimony on legislative proposals.
2015-05-05 14:31:09| Industrial Newsroom - All News for Today
Shane Kovacs, Executive VP & CFO of PTC Therapeutics, Inc., provided testimony on behalf of BIO before the U.S. House of Representatives Committee on Financial Services, Subcommittee on Capital Markets and Government Sponsored Enterprises, addressing legislative proposals to enhance capital formation and reduce regulatory burdens. Current bills being considered could help to further support the search for breakthrough treatments at emerging growth biotech companies.
Tags: leader
proposals
legislative
biotech
Gov. Inslee taps biotech community to brainstorm how to gain more capital
2015-05-05 00:22:09| Biotech - Topix.net
Gov. Jay Inslee talks at Cambia Grove in Seattle about the need to find innovative funding avenues for Washington state's biotech industry. More accessible angel investors and capital, more physical office and lab space for biotech companies and a better tax climate for companies large and small.
Tags: community
gov
capital
gain
Sites : [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] next »